Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 33 of 95, showing 5 Applications out of 474 total, starting on record 161, ending on 165

# Protocol No Study Title Investigator(s) & Site(s)

161.

ECCT/21/08/02   IPrEP Men\'s Study
    IPrEP Men’s Study: Expanding the reach of prevention for men in Kisumu, Kenya   
Principal Investigator(s)
1. Kawango Agot
2. Wafaa El-Sadr
Site(s) in Kenya
Kisumu Impact Research and Development Organization (K-IRDO) CRS
 
View

162.

ECCT/21/09/08   GBT133_Inclacumab Open-Label
    An Open-Label Extension Study to Evaluate the Long-Term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial   
Principal Investigator(s)
1. Fredrick Sirwa Chite
2. Bernhards Ragama Ogutu
3. Videlis N Nduba
4. Prof Jessie N Githanga
Site(s) in Kenya
1. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
2. KEMRI/CRDR (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrude’s Children’s Hospital. (Nairobi City county)
5. Strathmore University Medical Centre (Nairobi City county)
 
View

163.

ECCT/21/09/02   PrEDIRA - 2
    Piloting HIV Pre-exposure Prophylaxis (PrEP) Integration into Services for Early Pregnancy Loss   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. KEMRI-CCR PHRD THIKA - Thika, Nairobi, Murang\'a, and their environs (Kiambu county)
2. Kisumu clinical trial site - Kisumu and its enrvirons (Kisumu county)
3. Mariestopes - Nairobi (Nairobi City county)
 
View

164.

ECCT/21/07/04   Healthy Route
    A Non-Interventional Pilot Study to Evaluate A Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate from Digital Retinal Images   
Principal Investigator(s)
1. Mansoor Noorali Saleh
2. Videlis Nduba
Site(s) in Kenya
1. Aga Khan University Hospital Clinical Research Unit (Nairobi City county)
2. Kenya Medical Research Institute CRDR (Nairobi City county)
 
View

165.

ECCT/21/07/05   CARES
    A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine from Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults in Sub-Saharan Africa       
Principal Investigator(s)
1. Dr Reena Shah
Site(s) in Kenya
1. Aga Khan University Hospital Nairobi (Nairobi City county)
2. KEMRI Walter Reed Project (Kericho county)
3. Moi University Clinical Research Centre (Uasin Gishu county)
 
View